<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2024-10-02" version="247" xmlns="http://uniprot.org/uniprot">
  <accession>P50750</accession>
  <accession>Q5JU24</accession>
  <accession>Q5JU25</accession>
  <accession>Q5U006</accession>
  <accession>Q96TF1</accession>
  <name>CDK9_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Cyclin-dependent kinase 9</fullName>
      <ecNumber evidence="16 44">2.7.11.22</ecNumber>
      <ecNumber evidence="45 54">2.7.11.23</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>C-2K</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Cell division cycle 2-like protein kinase 4</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="62">Cell division protein kinase 9</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="63">Serine/threonine-protein kinase PITALRE</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Tat-associated kinase complex catalytic subunit</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="62 67" type="primary">CDK9</name>
    <name type="synonym">CDC2L4</name>
    <name type="synonym">TAK</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="3834" last="3838">
      <title>PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.</title>
      <authorList>
        <person name="Grana X."/>
        <person name="de Luca A."/>
        <person name="Sang N."/>
        <person name="Fu Y."/>
        <person name="Claudio P.P."/>
        <person name="Rosenblatt J."/>
        <person name="Morgan D.O."/>
        <person name="Giordano A."/>
      </authorList>
      <dbReference type="PubMed" id="8170997"/>
      <dbReference type="DOI" id="10.1073/pnas.91.9.3834"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1995" name="Biochem. Biophys. Res. Commun." volume="208" first="562" last="568">
      <title>Cloning of a full-length cDNA sequence encoding a cdc2-related protein kinase from human endothelial cells.</title>
      <authorList>
        <person name="Best J.L."/>
        <person name="Presky D.H."/>
        <person name="Swerlick R.A."/>
        <person name="Burns D.K."/>
        <person name="Chu W."/>
      </authorList>
      <dbReference type="PubMed" id="7695608"/>
      <dbReference type="DOI" id="10.1006/bbrc.1995.1375"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANT ALA-231</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2000" name="Gene" volume="252" first="51" last="59">
      <title>Genomic organization and characterization of promoter function of the human CDK9 gene.</title>
      <authorList>
        <person name="Liu H."/>
        <person name="Rice A.P."/>
      </authorList>
      <dbReference type="PubMed" id="10903437"/>
      <dbReference type="DOI" id="10.1016/s0378-1119(00)00215-8"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANT ALA-231</scope>
  </reference>
  <reference key="4">
    <citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
      <title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
      <authorList>
        <person name="Kalnine N."/>
        <person name="Chen X."/>
        <person name="Rolfs A."/>
        <person name="Halleck A."/>
        <person name="Hines L."/>
        <person name="Eisenstein S."/>
        <person name="Koundinya M."/>
        <person name="Raphael J."/>
        <person name="Moreira D."/>
        <person name="Kelley T."/>
        <person name="LaBaer J."/>
        <person name="Lin Y."/>
        <person name="Phelan M."/>
        <person name="Farmer A."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2002-06" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <consortium name="NIEHS SNPs program"/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
      <title>DNA sequence and analysis of human chromosome 9.</title>
      <authorList>
        <person name="Humphray S.J."/>
        <person name="Oliver K."/>
        <person name="Hunt A.R."/>
        <person name="Plumb R.W."/>
        <person name="Loveland J.E."/>
        <person name="Howe K.L."/>
        <person name="Andrews T.D."/>
        <person name="Searle S."/>
        <person name="Hunt S.E."/>
        <person name="Scott C.E."/>
        <person name="Jones M.C."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Ambrose K.D."/>
        <person name="Ashwell R.I.S."/>
        <person name="Babbage A.K."/>
        <person name="Babbage S."/>
        <person name="Bagguley C.L."/>
        <person name="Bailey J."/>
        <person name="Banerjee R."/>
        <person name="Barker D.J."/>
        <person name="Barlow K.F."/>
        <person name="Bates K."/>
        <person name="Beasley H."/>
        <person name="Beasley O."/>
        <person name="Bird C.P."/>
        <person name="Bray-Allen S."/>
        <person name="Brown A.J."/>
        <person name="Brown J.Y."/>
        <person name="Burford D."/>
        <person name="Burrill W."/>
        <person name="Burton J."/>
        <person name="Carder C."/>
        <person name="Carter N.P."/>
        <person name="Chapman J.C."/>
        <person name="Chen Y."/>
        <person name="Clarke G."/>
        <person name="Clark S.Y."/>
        <person name="Clee C.M."/>
        <person name="Clegg S."/>
        <person name="Collier R.E."/>
        <person name="Corby N."/>
        <person name="Crosier M."/>
        <person name="Cummings A.T."/>
        <person name="Davies J."/>
        <person name="Dhami P."/>
        <person name="Dunn M."/>
        <person name="Dutta I."/>
        <person name="Dyer L.W."/>
        <person name="Earthrowl M.E."/>
        <person name="Faulkner L."/>
        <person name="Fleming C.J."/>
        <person name="Frankish A."/>
        <person name="Frankland J.A."/>
        <person name="French L."/>
        <person name="Fricker D.G."/>
        <person name="Garner P."/>
        <person name="Garnett J."/>
        <person name="Ghori J."/>
        <person name="Gilbert J.G.R."/>
        <person name="Glison C."/>
        <person name="Grafham D.V."/>
        <person name="Gribble S."/>
        <person name="Griffiths C."/>
        <person name="Griffiths-Jones S."/>
        <person name="Grocock R."/>
        <person name="Guy J."/>
        <person name="Hall R.E."/>
        <person name="Hammond S."/>
        <person name="Harley J.L."/>
        <person name="Harrison E.S.I."/>
        <person name="Hart E.A."/>
        <person name="Heath P.D."/>
        <person name="Henderson C.D."/>
        <person name="Hopkins B.L."/>
        <person name="Howard P.J."/>
        <person name="Howden P.J."/>
        <person name="Huckle E."/>
        <person name="Johnson C."/>
        <person name="Johnson D."/>
        <person name="Joy A.A."/>
        <person name="Kay M."/>
        <person name="Keenan S."/>
        <person name="Kershaw J.K."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Knights A."/>
        <person name="Laird G.K."/>
        <person name="Langford C."/>
        <person name="Lawlor S."/>
        <person name="Leongamornlert D.A."/>
        <person name="Leversha M."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Lovell J."/>
        <person name="Martin S."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L."/>
        <person name="McLaren S."/>
        <person name="McLay K.E."/>
        <person name="McMurray A."/>
        <person name="Milne S."/>
        <person name="Nickerson T."/>
        <person name="Nisbett J."/>
        <person name="Nordsiek G."/>
        <person name="Pearce A.V."/>
        <person name="Peck A.I."/>
        <person name="Porter K.M."/>
        <person name="Pandian R."/>
        <person name="Pelan S."/>
        <person name="Phillimore B."/>
        <person name="Povey S."/>
        <person name="Ramsey Y."/>
        <person name="Rand V."/>
        <person name="Scharfe M."/>
        <person name="Sehra H.K."/>
        <person name="Shownkeen R."/>
        <person name="Sims S.K."/>
        <person name="Skuce C.D."/>
        <person name="Smith M."/>
        <person name="Steward C.A."/>
        <person name="Swarbreck D."/>
        <person name="Sycamore N."/>
        <person name="Tester J."/>
        <person name="Thorpe A."/>
        <person name="Tracey A."/>
        <person name="Tromans A."/>
        <person name="Thomas D.W."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="West A.P."/>
        <person name="Whitehead S.L."/>
        <person name="Willey D.L."/>
        <person name="Williams S.A."/>
        <person name="Wilming L."/>
        <person name="Wray P.W."/>
        <person name="Young L."/>
        <person name="Ashurst J.L."/>
        <person name="Coulson A."/>
        <person name="Blocker H."/>
        <person name="Durbin R.M."/>
        <person name="Sulston J.E."/>
        <person name="Hubbard T."/>
        <person name="Jackson M.J."/>
        <person name="Bentley D.R."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Dunham I."/>
      </authorList>
      <dbReference type="PubMed" id="15164053"/>
      <dbReference type="DOI" id="10.1038/nature02465"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Cervix</tissue>
    </source>
  </reference>
  <reference key="8">
    <citation type="journal article" date="1998" name="Cell" volume="92" first="451" last="462">
      <title>A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.</title>
      <authorList>
        <person name="Wei P."/>
        <person name="Garber M.E."/>
        <person name="Fang S.-M."/>
        <person name="Fischer W.H."/>
        <person name="Jones K.A."/>
      </authorList>
      <dbReference type="PubMed" id="9491887"/>
      <dbReference type="DOI" id="10.1016/s0092-8674(00)80939-3"/>
    </citation>
    <scope>INTERACTION WITH HIV TAT</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1998" name="EMBO J." volume="17" first="7395" last="7403">
      <title>Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.</title>
      <authorList>
        <person name="Wada T."/>
        <person name="Takagi T."/>
        <person name="Yamaguchi Y."/>
        <person name="Watanabe D."/>
        <person name="Handa H."/>
      </authorList>
      <dbReference type="PubMed" id="9857195"/>
      <dbReference type="DOI" id="10.1093/emboj/17.24.7395"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1998" name="Genes Dev." volume="12" first="755" last="762">
      <title>Identification of multiple cyclin subunits of human P-TEFb.</title>
      <authorList>
        <person name="Peng J.-M."/>
        <person name="Zhu Y."/>
        <person name="Milton J.T."/>
        <person name="Price D.H."/>
      </authorList>
      <dbReference type="PubMed" id="9499409"/>
      <dbReference type="DOI" id="10.1101/gad.12.5.755"/>
    </citation>
    <scope>IDENTIFICATION IN A COMPLEX WITH CCNT1 AND CCNT2</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
      <title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
      <authorList>
        <person name="Parada C.A."/>
        <person name="Roeder R.G."/>
      </authorList>
      <dbReference type="PubMed" id="10393184"/>
      <dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POL II; SUPT5H AND NCL</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34527" last="34530">
      <title>Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.</title>
      <authorList>
        <person name="Fu T.J."/>
        <person name="Peng J."/>
        <person name="Lee G."/>
        <person name="Price D.H."/>
        <person name="Flores O."/>
      </authorList>
      <dbReference type="PubMed" id="10574912"/>
      <dbReference type="DOI" id="10.1074/jbc.274.49.34527"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CCNK</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="1067" last="1072">
      <title>FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.</title>
      <authorList>
        <person name="Wada T."/>
        <person name="Orphanides G."/>
        <person name="Hasegawa J."/>
        <person name="Kim D.-K."/>
        <person name="Shima D."/>
        <person name="Yamaguchi Y."/>
        <person name="Fukuda A."/>
        <person name="Hisatake K."/>
        <person name="Oh S."/>
        <person name="Reinberg D."/>
        <person name="Handa H."/>
      </authorList>
      <dbReference type="PubMed" id="10912001"/>
      <dbReference type="DOI" id="10.1016/s1097-2765(00)80272-5"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="2970" last="2983">
      <title>Domains in the SPT5 protein that modulate its transcriptional regulatory properties.</title>
      <authorList>
        <person name="Ivanov D."/>
        <person name="Kwak Y.T."/>
        <person name="Guo J."/>
        <person name="Gaynor R.B."/>
      </authorList>
      <dbReference type="PubMed" id="10757782"/>
      <dbReference type="DOI" id="10.1128/mcb.20.9.2970-2983.2000"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="6958" last="6969">
      <title>CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.</title>
      <authorList>
        <person name="Garber M.E."/>
        <person name="Mayall T.P."/>
        <person name="Suess E.M."/>
        <person name="Meisenhelder J."/>
        <person name="Thompson N.E."/>
        <person name="Jones K.A."/>
      </authorList>
      <dbReference type="PubMed" id="10958691"/>
      <dbReference type="DOI" id="10.1128/mcb.20.18.6958-6969.2000"/>
    </citation>
    <scope>PHOSPHORYLATION BY PKA</scope>
    <scope>AUTOPHOSPHORYLATION</scope>
    <scope>PHOSPHORYLATION AT SER-347; THR-350; SER-353; THR-354 AND SER-357</scope>
    <scope>INTERACTION WITH HIV TAT</scope>
    <scope>MUTAGENESIS OF 347-SER--SER-357 AND ASP-167</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12317" last="12323">
      <title>Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.</title>
      <authorList>
        <person name="Kim J.B."/>
        <person name="Sharp P.A."/>
      </authorList>
      <dbReference type="PubMed" id="11145967"/>
      <dbReference type="DOI" id="10.1074/jbc.m010908200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF ASP-167 AND THR-186</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12951" last="12958">
      <title>DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.</title>
      <authorList>
        <person name="Ping Y.-H."/>
        <person name="Rana T.M."/>
      </authorList>
      <dbReference type="PubMed" id="11112772"/>
      <dbReference type="DOI" id="10.1074/jbc.m006130200"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2001" name="J. Mol. Biol." volume="312" first="675" last="685">
      <title>The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9.</title>
      <authorList>
        <person name="Lavoie S.B."/>
        <person name="Albert A.L."/>
        <person name="Handa H."/>
        <person name="Vincent M."/>
        <person name="Bensaude O."/>
      </authorList>
      <dbReference type="PubMed" id="11575923"/>
      <dbReference type="DOI" id="10.1006/jmbi.2001.4991"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16873" last="16878">
      <title>P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.</title>
      <authorList>
        <person name="Lin X."/>
        <person name="Taube R."/>
        <person name="Fujinaga K."/>
        <person name="Peterlin B.M."/>
      </authorList>
      <dbReference type="PubMed" id="11884399"/>
      <dbReference type="DOI" id="10.1074/jbc.m200117200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CCNK/CYCLIN K</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2002" name="J. Biomed. Sci." volume="9" first="234" last="245">
      <title>MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.</title>
      <authorList>
        <person name="Estable M.C."/>
        <person name="Naghavi M.H."/>
        <person name="Kato H."/>
        <person name="Xiao H."/>
        <person name="Qin J."/>
        <person name="Vahlne A."/>
        <person name="Roeder R.G."/>
      </authorList>
      <dbReference type="PubMed" id="12065898"/>
      <dbReference type="DOI" id="10.1007/bf02256070"/>
    </citation>
    <scope>INTERACTION WITH AFF4</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2002" name="J. Cell. Physiol." volume="192" first="209" last="215">
      <title>CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization.</title>
      <authorList>
        <person name="Napolitano G."/>
        <person name="Licciardo P."/>
        <person name="Carbone R."/>
        <person name="Majello B."/>
        <person name="Lania L."/>
      </authorList>
      <dbReference type="PubMed" id="12115727"/>
      <dbReference type="DOI" id="10.1002/jcp.10130"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1079" last="1093">
      <title>Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.</title>
      <authorList>
        <person name="Bourgeois C.F."/>
        <person name="Kim Y.K."/>
        <person name="Churcher M.J."/>
        <person name="West M.J."/>
        <person name="Karn J."/>
      </authorList>
      <dbReference type="PubMed" id="11809800"/>
      <dbReference type="DOI" id="10.1128/mcb.22.4.1079-1093.2002"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2002" name="Oncogene" volume="21" first="4137" last="4148">
      <title>Activation of MyoD-dependent transcription by cdk9/cyclin T2.</title>
      <authorList>
        <person name="Simone C."/>
        <person name="Stiegler P."/>
        <person name="Bagella L."/>
        <person name="Pucci B."/>
        <person name="Bellan C."/>
        <person name="De Falco G."/>
        <person name="De Luca A."/>
        <person name="Guanti G."/>
        <person name="Puri P.L."/>
        <person name="Giordano A."/>
      </authorList>
      <dbReference type="PubMed" id="12037670"/>
      <dbReference type="DOI" id="10.1038/sj.onc.1205493"/>
    </citation>
    <scope>FUNCTION AS MYOD1 KINASE</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH MYOD1 AND CCNT2</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="1055" last="1066">
      <title>Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.</title>
      <authorList>
        <person name="Kwak Y.T."/>
        <person name="Guo J."/>
        <person name="Prajapati S."/>
        <person name="Park K.-J."/>
        <person name="Surabhi R.M."/>
        <person name="Miller B."/>
        <person name="Gehrig P."/>
        <person name="Gaynor R.B."/>
      </authorList>
      <dbReference type="PubMed" id="12718890"/>
      <dbReference type="DOI" id="10.1016/s1097-2765(03)00101-1"/>
    </citation>
    <scope>INTERACTION WITH SUPT5H</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2004" name="J. Virol." volume="78" first="13522" last="13533">
      <title>Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.</title>
      <authorList>
        <person name="Zhou M."/>
        <person name="Deng L."/>
        <person name="Lacoste V."/>
        <person name="Park H.U."/>
        <person name="Pumfery A."/>
        <person name="Kashanchi F."/>
        <person name="Brady J.N."/>
        <person name="Kumar A."/>
      </authorList>
      <dbReference type="PubMed" id="15564463"/>
      <dbReference type="DOI" id="10.1128/jvi.78.24.13522-13533.2004"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="787" last="795">
      <title>Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.</title>
      <authorList>
        <person name="Fujinaga K."/>
        <person name="Irwin D."/>
        <person name="Huang Y."/>
        <person name="Taube R."/>
        <person name="Kurosu T."/>
        <person name="Peterlin B.M."/>
      </authorList>
      <dbReference type="PubMed" id="14701750"/>
      <dbReference type="DOI" id="10.1128/mcb.24.2.787-795.2004"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28819" last="28826">
      <title>Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.</title>
      <authorList>
        <person name="Li Q."/>
        <person name="Price J.P."/>
        <person name="Byers S.A."/>
        <person name="Cheng D."/>
        <person name="Peng J."/>
        <person name="Price D.H."/>
      </authorList>
      <dbReference type="PubMed" id="15965233"/>
      <dbReference type="DOI" id="10.1074/jbc.m502712200"/>
    </citation>
    <scope>IDENTIFICATION IN INACTIVE 7SK SNRNP COMPLEX</scope>
    <scope>PHOSPHORYLATION AT THR-186</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="523" last="534">
      <title>The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.</title>
      <authorList>
        <person name="Jang M.K."/>
        <person name="Mochizuki K."/>
        <person name="Zhou M."/>
        <person name="Jeong H.S."/>
        <person name="Brady J.N."/>
        <person name="Ozato K."/>
      </authorList>
      <dbReference type="PubMed" id="16109376"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2005.06.027"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH BRD4</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="535" last="545">
      <title>Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.</title>
      <authorList>
        <person name="Yang Z."/>
        <person name="Yik J.H."/>
        <person name="Chen R."/>
        <person name="He N."/>
        <person name="Jang M.K."/>
        <person name="Ozato K."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="16109377"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2005.06.029"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH BRD4</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="37091" last="37102">
      <title>The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.</title>
      <authorList>
        <person name="Hou T."/>
        <person name="Ray S."/>
        <person name="Brasier A.R."/>
      </authorList>
      <dbReference type="PubMed" id="17956865"/>
      <dbReference type="DOI" id="10.1074/jbc.m706458200"/>
    </citation>
    <scope>FUNCTION IN CYTOKINE SIGNALING</scope>
    <scope>INTERACTION WITH STAT3</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="262" last="274">
      <title>Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.</title>
      <authorList>
        <person name="Jeronimo C."/>
        <person name="Forget D."/>
        <person name="Bouchard A."/>
        <person name="Li Q."/>
        <person name="Chua G."/>
        <person name="Poitras C."/>
        <person name="Therien C."/>
        <person name="Bergeron D."/>
        <person name="Bourassa S."/>
        <person name="Greenblatt J."/>
        <person name="Chabot B."/>
        <person name="Poirier G.G."/>
        <person name="Hughes T.R."/>
        <person name="Blanchette M."/>
        <person name="Price D.H."/>
        <person name="Coulombe B."/>
      </authorList>
      <dbReference type="PubMed" id="17643375"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2007.06.027"/>
    </citation>
    <scope>IDENTIFICATION IN THE 7SK SNRNP COMPLEX</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="4641" last="4651">
      <title>Regulation of P-TEFb elongation complex activity by CDK9 acetylation.</title>
      <authorList>
        <person name="Fu J."/>
        <person name="Yoon H.-G."/>
        <person name="Qin J."/>
        <person name="Wong J."/>
      </authorList>
      <dbReference type="PubMed" id="17452463"/>
      <dbReference type="DOI" id="10.1128/mcb.00857-06"/>
    </citation>
    <scope>ACETYLATION AT LYS-44</scope>
    <scope>IDENTIFICATION IN COMPLEX WITH NCOR1; HEXIM1 AND HDAC3</scope>
    <scope>MUTAGENESIS OF LYS-44</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2008" name="Genes Dev." volume="22" first="1356" last="1368">
      <title>PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.</title>
      <authorList>
        <person name="Chen R."/>
        <person name="Liu M."/>
        <person name="Li H."/>
        <person name="Xue Y."/>
        <person name="Ramey W.N."/>
        <person name="He N."/>
        <person name="Ai N."/>
        <person name="Luo H."/>
        <person name="Zhu Y."/>
        <person name="Zhou N."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="18483222"/>
      <dbReference type="DOI" id="10.1101/gad.1636008"/>
    </citation>
    <scope>PHOSPHORYLATION AT THR-186</scope>
    <scope>DEPHOSPHORYLATION BY PPP1CA</scope>
    <scope>P-TEFB/7SK SNRNP COMPLEX</scope>
    <scope>SUBUNIT</scope>
    <scope>INTERACTION WITH BRD4</scope>
    <scope>ACTIVITY REGULATION</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="33578" last="33584">
      <title>Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.</title>
      <authorList>
        <person name="Wang Y."/>
        <person name="Dow E.C."/>
        <person name="Liang Y.Y."/>
        <person name="Ramakrishnan R."/>
        <person name="Liu H."/>
        <person name="Sung T.L."/>
        <person name="Lin X."/>
        <person name="Rice A.P."/>
      </authorList>
      <dbReference type="PubMed" id="18829461"/>
      <dbReference type="DOI" id="10.1074/jbc.m807495200"/>
    </citation>
    <scope>PHOSPHORYLATION AT THR-186</scope>
    <scope>DEPHOSPHORYLATION BY PPM1A AND PPM1B</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="588" last="599">
      <title>A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis.</title>
      <authorList>
        <person name="He N."/>
        <person name="Jahchan N.S."/>
        <person name="Hong E."/>
        <person name="Li Q."/>
        <person name="Bayfield M.A."/>
        <person name="Maraia R.J."/>
        <person name="Luo K."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="18249148"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2008.01.003"/>
    </citation>
    <scope>IDENTIFICATION IN COMPLEX WITH LARP7 IN 7SK SNRNP COMPLEX</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
      <title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
      <authorList>
        <person name="Daub H."/>
        <person name="Olsen J.V."/>
        <person name="Bairlein M."/>
        <person name="Gnad F."/>
        <person name="Oppermann F.S."/>
        <person name="Korner R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Stemmann O."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="18691976"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 (ISOFORM 2)</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="2201" last="2212">
      <title>Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.</title>
      <authorList>
        <person name="Sabo A."/>
        <person name="Lusic M."/>
        <person name="Cereseto A."/>
        <person name="Giacca M."/>
      </authorList>
      <dbReference type="PubMed" id="18250157"/>
      <dbReference type="DOI" id="10.1128/mcb.01557-07"/>
    </citation>
    <scope>ACETYLATION AT LYS-44 AND LYS-48 BY PCAF/KAT2B AND GCN5/KAT2A</scope>
    <scope>ACTIVITY REGULATION BY ACETYLATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="3623" last="3638">
      <title>RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes.</title>
      <authorList>
        <person name="Nowak D.E."/>
        <person name="Tian B."/>
        <person name="Jamaluddin M."/>
        <person name="Boldogh I."/>
        <person name="Vergara L.A."/>
        <person name="Choudhary S."/>
        <person name="Brasier A.R."/>
      </authorList>
      <dbReference type="PubMed" id="18362169"/>
      <dbReference type="DOI" id="10.1128/mcb.01152-07"/>
    </citation>
    <scope>FUNCTION IN CYTOKINE SIGNALING</scope>
    <scope>INTERACTION WITH RELA/P65</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2009" name="Cell Cycle" volume="8" first="3636" last="3642">
      <title>Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing.</title>
      <authorList>
        <person name="Pirngruber J."/>
        <person name="Shchebet A."/>
        <person name="Johnsen S.A."/>
      </authorList>
      <dbReference type="PubMed" id="19844166"/>
      <dbReference type="DOI" id="10.4161/cc.8.22.9890"/>
    </citation>
    <scope>FUNCTION IN HISTONE REGULATION</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="894" last="900">
      <title>CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing.</title>
      <authorList>
        <person name="Pirngruber J."/>
        <person name="Shchebet A."/>
        <person name="Schreiber L."/>
        <person name="Shema E."/>
        <person name="Minsky N."/>
        <person name="Chapman R.D."/>
        <person name="Eick D."/>
        <person name="Aylon Y."/>
        <person name="Oren M."/>
        <person name="Johnsen S.A."/>
      </authorList>
      <dbReference type="PubMed" id="19575011"/>
      <dbReference type="DOI" id="10.1038/embor.2009.108"/>
    </citation>
    <scope>FUNCTION IN HISTONE H2B UBIQUITINATION</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
      <title>Large-scale proteomics analysis of the human kinome.</title>
      <authorList>
        <person name="Oppermann F.S."/>
        <person name="Gnad F."/>
        <person name="Olsen J.V."/>
        <person name="Hornberger R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Mann M."/>
        <person name="Daub H."/>
      </authorList>
      <dbReference type="PubMed" id="19369195"/>
      <dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347 AND THR-350</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 (ISOFORM 2)</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="397" first="245" last="250">
      <title>55K isoform of CDK9 associates with Ku70 and is involved in DNA repair.</title>
      <authorList>
        <person name="Liu H."/>
        <person name="Herrmann C.H."/>
        <person name="Chiang K."/>
        <person name="Sung T.L."/>
        <person name="Moon S.H."/>
        <person name="Donehower L.A."/>
        <person name="Rice A.P."/>
      </authorList>
      <dbReference type="PubMed" id="20493174"/>
      <dbReference type="DOI" id="10.1016/j.bbrc.2010.05.092"/>
    </citation>
    <scope>FUNCTION IN DNA REPAIR</scope>
    <scope>INTERACTION WITH KU70/XRCC6</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2010" name="EMBO Rep." volume="11" first="876" last="882">
      <title>Cyclin-dependent kinase 9-cyclin K functions in the replication stress response.</title>
      <authorList>
        <person name="Yu D.S."/>
        <person name="Zhao R."/>
        <person name="Hsu E.L."/>
        <person name="Cayer J."/>
        <person name="Ye F."/>
        <person name="Guo Y."/>
        <person name="Shyr Y."/>
        <person name="Cortez D."/>
      </authorList>
      <dbReference type="PubMed" id="20930849"/>
      <dbReference type="DOI" id="10.1038/embor.2010.153"/>
    </citation>
    <scope>FUNCTION IN CDK9/CYCLIN K COMPLEX DURING REPLICATION STRESS</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="9556" last="9568">
      <title>Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.</title>
      <authorList>
        <person name="Sunagawa Y."/>
        <person name="Morimoto T."/>
        <person name="Takaya T."/>
        <person name="Kaichi S."/>
        <person name="Wada H."/>
        <person name="Kawamura T."/>
        <person name="Fujita M."/>
        <person name="Shimatsu A."/>
        <person name="Kita T."/>
        <person name="Hasegawa K."/>
      </authorList>
      <dbReference type="PubMed" id="20081228"/>
      <dbReference type="DOI" id="10.1074/jbc.m109.070458"/>
    </citation>
    <scope>FUNCTION IN CARDIAC HYPERTROPHY</scope>
    <scope>IDENTIFICATION IN COMPLEX WITH CCNT1/CYCLIN-T1; EP300 AND GATA4</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2010" name="Mol. Cell" volume="38" first="428" last="438">
      <title>HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.</title>
      <authorList>
        <person name="He N."/>
        <person name="Liu M."/>
        <person name="Hsu J."/>
        <person name="Xue Y."/>
        <person name="Chou S."/>
        <person name="Burlingame A."/>
        <person name="Krogan N.J."/>
        <person name="Alber T."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="20471948"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2010.04.013"/>
    </citation>
    <scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="429" last="437">
      <title>AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.</title>
      <authorList>
        <person name="Lin C."/>
        <person name="Smith E.R."/>
        <person name="Takahashi H."/>
        <person name="Lai K.C."/>
        <person name="Martin-Brown S."/>
        <person name="Florens L."/>
        <person name="Washburn M.P."/>
        <person name="Conaway J.W."/>
        <person name="Conaway R.C."/>
        <person name="Shilatifard A."/>
      </authorList>
      <dbReference type="PubMed" id="20159561"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2010.01.026"/>
    </citation>
    <scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2010" name="Mol. Endocrinol." volume="24" first="2267" last="2280">
      <title>CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.</title>
      <authorList>
        <person name="Gordon V."/>
        <person name="Bhadel S."/>
        <person name="Wunderlich W."/>
        <person name="Zhang J."/>
        <person name="Ficarro S.B."/>
        <person name="Mollah S.A."/>
        <person name="Shabanowitz J."/>
        <person name="Hunt D.F."/>
        <person name="Xenarios I."/>
        <person name="Hahn W.C."/>
        <person name="Conaway M."/>
        <person name="Carey M.F."/>
        <person name="Gioeli D."/>
      </authorList>
      <dbReference type="PubMed" id="20980437"/>
      <dbReference type="DOI" id="10.1210/me.2010-0238"/>
    </citation>
    <scope>FUNCTION IN AR KINASE</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH AR</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2011" name="Mol. Cell" volume="44" first="954" last="965">
      <title>The little elongation complex regulates small nuclear RNA transcription.</title>
      <authorList>
        <person name="Smith E.R."/>
        <person name="Lin C."/>
        <person name="Garrett A.S."/>
        <person name="Thornton J."/>
        <person name="Mohaghegh N."/>
        <person name="Hu D."/>
        <person name="Jackson J."/>
        <person name="Saraf A."/>
        <person name="Swanson S.K."/>
        <person name="Seidel C."/>
        <person name="Florens L."/>
        <person name="Washburn M.P."/>
        <person name="Eissenberg J.C."/>
        <person name="Shilatifard A."/>
      </authorList>
      <dbReference type="PubMed" id="22195968"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2011.12.008"/>
    </citation>
    <scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-186</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2012" name="Int. J. Cancer" volume="130" first="1216" last="1226">
      <title>CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol.</title>
      <authorList>
        <person name="Liu X."/>
        <person name="Shi S."/>
        <person name="Lam F."/>
        <person name="Pepper C."/>
        <person name="Fischer P.M."/>
        <person name="Wang S."/>
      </authorList>
      <dbReference type="PubMed" id="21484792"/>
      <dbReference type="DOI" id="10.1002/ijc.26127"/>
    </citation>
    <scope>ACTIVITY REGULATION BY CDKI-71</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5012" last="5022">
      <title>Transcription factor IIS cooperates with the E3 ligase UBR5 to ubiquitinate the CDK9 subunit of the positive transcription elongation factor B.</title>
      <authorList>
        <person name="Cojocaru M."/>
        <person name="Bouchard A."/>
        <person name="Cloutier P."/>
        <person name="Cooper J.J."/>
        <person name="Varzavand K."/>
        <person name="Price D.H."/>
        <person name="Coulombe B."/>
      </authorList>
      <dbReference type="PubMed" id="21127351"/>
      <dbReference type="DOI" id="10.1074/jbc.m110.176628"/>
    </citation>
    <scope>FUNCTION AS RPB1/POLR2A CTD KINASE</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>POLYUBIQUITINATION BY UBR5</scope>
    <scope>INTERACTION WITH UBR5 AND TFIIS/TCEA1</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2012" name="J. Cell. Physiol." volume="227" first="609" last="617">
      <title>Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.</title>
      <authorList>
        <person name="Ramakrishnan R."/>
        <person name="Rice A.P."/>
      </authorList>
      <dbReference type="PubMed" id="21448926"/>
      <dbReference type="DOI" id="10.1002/jcp.22760"/>
    </citation>
    <scope>PHOSPHORYLATION AT THR-186</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DEGRADATION BY THE PROTEASOME</scope>
    <scope>MUTAGENESIS OF THR-186</scope>
  </reference>
  <reference key="54">
    <citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E18985" last="E18985">
      <title>Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175.</title>
      <authorList>
        <person name="Ammosova T."/>
        <person name="Obukhov Y."/>
        <person name="Kotelkin A."/>
        <person name="Breuer D."/>
        <person name="Beullens M."/>
        <person name="Gordeuk V.R."/>
        <person name="Bollen M."/>
        <person name="Nekhai S."/>
      </authorList>
      <dbReference type="PubMed" id="21533037"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0018985"/>
    </citation>
    <scope>PHOSPHORYLATION AT SER-175</scope>
    <scope>DEPHOSPHORYLATION AT SER-175 BY PP1</scope>
    <scope>MUTAGENESIS OF SER-175</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="2006" name="Mol. Cell" volume="23" first="297" last="305">
      <title>Controlling the elongation phase of transcription with P-TEFb.</title>
      <authorList>
        <person name="Peterlin B.M."/>
        <person name="Price D.H."/>
      </authorList>
      <dbReference type="PubMed" id="16885020"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2006.06.014"/>
    </citation>
    <scope>REVIEW ON NELF AND DSIF KINASE ACTIVITY</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="2661" last="2666">
      <title>Expanding role of cyclin dependent kinases in cytokine inducible gene expression.</title>
      <authorList>
        <person name="Brasier A.R."/>
      </authorList>
      <dbReference type="PubMed" id="18728388"/>
      <dbReference type="DOI" id="10.4161/cc.7.17.6594"/>
    </citation>
    <scope>REVIEW ON CYTOKINE SIGNALING</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="3664" last="3668">
      <title>Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases.</title>
      <authorList>
        <person name="Romano G."/>
        <person name="Giordano A."/>
      </authorList>
      <dbReference type="PubMed" id="19029809"/>
      <dbReference type="DOI" id="10.4161/cc.7.23.7122"/>
    </citation>
    <scope>REVIEW ON TRANSCRIPTION REGULATION</scope>
    <scope>INHIBITORS</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="2008" name="Trends Pharmacol. Sci." volume="29" first="302" last="313">
      <title>Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.</title>
      <authorList>
        <person name="Wang S."/>
        <person name="Fischer P.M."/>
      </authorList>
      <dbReference type="PubMed" id="18423896"/>
      <dbReference type="DOI" id="10.1016/j.tips.2008.03.003"/>
    </citation>
    <scope>REVIEW ON TRANSCRIPTION REGULATION</scope>
    <scope>INHIBITORS</scope>
  </reference>
  <reference key="59">
    <citation type="journal article" date="2009" name="Nat. Rev. Cancer" volume="9" first="153" last="166">
      <title>Cell cycle, CDKs and cancer: a changing paradigm.</title>
      <authorList>
        <person name="Malumbres M."/>
        <person name="Barbacid M."/>
      </authorList>
      <dbReference type="PubMed" id="19238148"/>
      <dbReference type="DOI" id="10.1038/nrc2602"/>
    </citation>
    <scope>ACTIVITY REGULATION</scope>
    <scope>GENE FAMILY</scope>
  </reference>
  <reference key="60">
    <citation type="journal article" date="2010" name="Med. Res. Rev." volume="30" first="646" last="666">
      <title>Pharmacological targeting of CDK9 in cardiac hypertrophy.</title>
      <authorList>
        <person name="Krystof V."/>
        <person name="Chamrad I."/>
        <person name="Jorda R."/>
        <person name="Kohoutek J."/>
      </authorList>
      <dbReference type="PubMed" id="19757441"/>
      <dbReference type="DOI" id="10.1002/med.20172"/>
    </citation>
    <scope>REVIEW ON CARDIAC HYPERTROPHY</scope>
    <scope>INHIBITORS</scope>
  </reference>
  <reference key="61">
    <citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="28" last="32">
      <title>A role for cdk9-cyclin k in maintaining genome integrity.</title>
      <authorList>
        <person name="Yu D.S."/>
        <person name="Cortez D."/>
      </authorList>
      <dbReference type="PubMed" id="21200140"/>
      <dbReference type="DOI" id="10.4161/cc.10.1.14364"/>
    </citation>
    <scope>REVIEW ON GENOME INTEGRITY MAINTENANCE</scope>
  </reference>
  <reference key="62">
    <citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E45749" last="E45749">
      <title>Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb.</title>
      <authorList>
        <person name="Guo L."/>
        <person name="Wu W.J."/>
        <person name="Liu L.D."/>
        <person name="Wang L.C."/>
        <person name="Zhang Y."/>
        <person name="Wu L.Q."/>
        <person name="Guan Y."/>
        <person name="Li Q.H."/>
      </authorList>
      <dbReference type="PubMed" id="23029222"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0045749"/>
    </citation>
    <scope>INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="63">
    <citation type="journal article" date="2013" name="Cell" volume="155" first="1581" last="1595">
      <title>Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.</title>
      <authorList>
        <person name="Liu W."/>
        <person name="Ma Q."/>
        <person name="Wong K."/>
        <person name="Li W."/>
        <person name="Ohgi K."/>
        <person name="Zhang J."/>
        <person name="Aggarwal A."/>
        <person name="Rosenfeld M.G."/>
      </authorList>
      <dbReference type="PubMed" id="24360279"/>
      <dbReference type="DOI" id="10.1016/j.cell.2013.10.056"/>
    </citation>
    <scope>INTERACTION WITH BRD4 AND JMJD6</scope>
  </reference>
  <reference key="64">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-54 (ISOFORM 2)</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="65">
    <citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="e107654" last="e107654">
      <title>Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation.</title>
      <authorList>
        <person name="Zaborowska J."/>
        <person name="Baumli S."/>
        <person name="Laitem C."/>
        <person name="O'Reilly D."/>
        <person name="Thomas P.H."/>
        <person name="O'Hare P."/>
        <person name="Murphy S."/>
      </authorList>
      <dbReference type="PubMed" id="25233083"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0107654"/>
    </citation>
    <scope>INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="66">
    <citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="26294" last="26294">
      <title>Heat shock factor 1 mediates latent HIV reactivation.</title>
      <authorList>
        <person name="Pan X.Y."/>
        <person name="Zhao W."/>
        <person name="Zeng X.Y."/>
        <person name="Lin J."/>
        <person name="Li M.M."/>
        <person name="Shen X.T."/>
        <person name="Liu S.W."/>
      </authorList>
      <dbReference type="PubMed" id="27189267"/>
      <dbReference type="DOI" id="10.1038/srep26294"/>
    </citation>
    <scope>INTERACTION WITH HSF1</scope>
  </reference>
  <reference key="67">
    <citation type="journal article" date="2017" name="Nucleic Acids Res." volume="45" first="2675" last="2686">
      <title>SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription.</title>
      <authorList>
        <person name="Blank M.F."/>
        <person name="Chen S."/>
        <person name="Poetz F."/>
        <person name="Schnoelzer M."/>
        <person name="Voit R."/>
        <person name="Grummt I."/>
      </authorList>
      <dbReference type="PubMed" id="28426094"/>
      <dbReference type="DOI" id="10.1093/nar/gkx053"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACETYLATION AT LYS-48</scope>
    <scope>DEACETYLATION BY SIRT7</scope>
    <scope>MUTAGENESIS OF LYS-48</scope>
  </reference>
  <reference key="68">
    <citation type="journal article" date="2018" name="Cell Rep." volume="24" first="2141" last="2154">
      <title>Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex.</title>
      <authorList>
        <person name="Ghosh K."/>
        <person name="Tang M."/>
        <person name="Kumari N."/>
        <person name="Nandy A."/>
        <person name="Basu S."/>
        <person name="Mall D.P."/>
        <person name="Rai K."/>
        <person name="Biswas D."/>
      </authorList>
      <dbReference type="PubMed" id="30134174"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2018.07.064"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH HEXIM1; AFF4; MLLT3; ZMYND8 AND CCNT1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="69">
    <citation type="journal article" date="2018" name="EMBO Rep." volume="19" first="244" last="256">
      <title>CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery.</title>
      <authorList>
        <person name="Brauns-Schubert P."/>
        <person name="Schubert F."/>
        <person name="Wissler M."/>
        <person name="Weiss M."/>
        <person name="Schlicher L."/>
        <person name="Bessler S."/>
        <person name="Safavi M."/>
        <person name="Miething C."/>
        <person name="Borner C."/>
        <person name="Brummer T."/>
        <person name="Maurer U."/>
      </authorList>
      <dbReference type="PubMed" id="29335245"/>
      <dbReference type="DOI" id="10.15252/embr.201744311"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="70">
    <citation type="journal article" date="2021" name="Vaccines (Basel)" volume="9">
      <title>HSV-1 ICP22 Is a Selective Viral Repressor of Cellular RNA Polymerase II-Mediated Transcription Elongation.</title>
      <authorList>
        <person name="Isa N.F."/>
        <person name="Bensaude O."/>
        <person name="Aziz N.C."/>
        <person name="Murphy S."/>
      </authorList>
      <dbReference type="PubMed" id="34696162"/>
      <dbReference type="DOI" id="10.3390/vaccines9101054"/>
    </citation>
    <scope>INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="71">
    <citation type="journal article" date="2010" name="Nature" volume="465" first="747" last="751">
      <title>Crystal structure of HIV-1 Tat complexed with human P-TEFb.</title>
      <authorList>
        <person name="Tahirov T.H."/>
        <person name="Babayeva N.D."/>
        <person name="Varzavand K."/>
        <person name="Cooper J.J."/>
        <person name="Sedore S.C."/>
        <person name="Price D.H."/>
      </authorList>
      <dbReference type="PubMed" id="20535204"/>
      <dbReference type="DOI" id="10.1038/nature09131"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-345 IN COMPLEX WITH HIV-1 TAT AND CCNT1</scope>
    <scope>PHOSPHORYLATION AT THR-186</scope>
  </reference>
  <reference key="72">
    <citation type="journal article" date="2008" name="EMBO J." volume="27" first="1907" last="1918">
      <title>The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.</title>
      <authorList>
        <person name="Baumli S."/>
        <person name="Lolli G."/>
        <person name="Lowe E.D."/>
        <person name="Troiani S."/>
        <person name="Rusconi L."/>
        <person name="Bullock A.N."/>
        <person name="Debreczeni J.E."/>
        <person name="Knapp S."/>
        <person name="Johnson L.N."/>
      </authorList>
      <dbReference type="PubMed" id="18566585"/>
      <dbReference type="DOI" id="10.1038/emboj.2008.121"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR FLAVOPIRIDOL; ATP AND CCNT1</scope>
    <scope>PHOSPHORYLATION AT THR-186 SER-347; THR-362 AND THR-363</scope>
    <scope>AUTOPHOSPHORYLATION</scope>
    <scope>MUTAGENESIS OF THR-186</scope>
  </reference>
  <reference key="73">
    <citation type="journal article" date="2010" name="Chem. Biol." volume="17" first="931" last="936">
      <title>Halogen bonds form the basis for selective P-TEFb inhibition by DRB.</title>
      <authorList>
        <person name="Baumli S."/>
        <person name="Endicott J.A."/>
        <person name="Johnson L.N."/>
      </authorList>
      <dbReference type="PubMed" id="20851342"/>
      <dbReference type="DOI" id="10.1016/j.chembiol.2010.07.012"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR DRB</scope>
    <scope>PHOSPHORYLATION AT THR-186</scope>
  </reference>
  <reference key="74">
    <citation type="journal article" date="2010" name="Genes Cancer" volume="1" first="369" last="380">
      <title>CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells.</title>
      <authorList>
        <person name="Bettayeb K."/>
        <person name="Baunbaek D."/>
        <person name="Delehouze C."/>
        <person name="Loaec N."/>
        <person name="Hole A.J."/>
        <person name="Baumli S."/>
        <person name="Endicott J.A."/>
        <person name="Douc-Rasy S."/>
        <person name="Benard J."/>
        <person name="Oumata N."/>
        <person name="Galons H."/>
        <person name="Meijer L."/>
      </authorList>
      <dbReference type="PubMed" id="21779453"/>
      <dbReference type="DOI" id="10.1177/1947601910369817"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-330 IN COMPLEX WITH CCNT1; INHIBITORS ROSCOVITINE AND CR8</scope>
    <scope>PHOSPHORYLATION AT THR-186</scope>
    <scope>ACTIVITY REGULATION</scope>
  </reference>
  <reference key="75">
    <citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
      <title>Patterns of somatic mutation in human cancer genomes.</title>
      <authorList>
        <person name="Greenman C."/>
        <person name="Stephens P."/>
        <person name="Smith R."/>
        <person name="Dalgliesh G.L."/>
        <person name="Hunter C."/>
        <person name="Bignell G."/>
        <person name="Davies H."/>
        <person name="Teague J."/>
        <person name="Butler A."/>
        <person name="Stevens C."/>
        <person name="Edkins S."/>
        <person name="O'Meara S."/>
        <person name="Vastrik I."/>
        <person name="Schmidt E.E."/>
        <person name="Avis T."/>
        <person name="Barthorpe S."/>
        <person name="Bhamra G."/>
        <person name="Buck G."/>
        <person name="Choudhury B."/>
        <person name="Clements J."/>
        <person name="Cole J."/>
        <person name="Dicks E."/>
        <person name="Forbes S."/>
        <person name="Gray K."/>
        <person name="Halliday K."/>
        <person name="Harrison R."/>
        <person name="Hills K."/>
        <person name="Hinton J."/>
        <person name="Jenkinson A."/>
        <person name="Jones D."/>
        <person name="Menzies A."/>
        <person name="Mironenko T."/>
        <person name="Perry J."/>
        <person name="Raine K."/>
        <person name="Richardson D."/>
        <person name="Shepherd R."/>
        <person name="Small A."/>
        <person name="Tofts C."/>
        <person name="Varian J."/>
        <person name="Webb T."/>
        <person name="West S."/>
        <person name="Widaa S."/>
        <person name="Yates A."/>
        <person name="Cahill D.P."/>
        <person name="Louis D.N."/>
        <person name="Goldstraw P."/>
        <person name="Nicholson A.G."/>
        <person name="Brasseur F."/>
        <person name="Looijenga L."/>
        <person name="Weber B.L."/>
        <person name="Chiew Y.-E."/>
        <person name="DeFazio A."/>
        <person name="Greaves M.F."/>
        <person name="Green A.R."/>
        <person name="Campbell P."/>
        <person name="Birney E."/>
        <person name="Easton D.F."/>
        <person name="Chenevix-Trench G."/>
        <person name="Tan M.-H."/>
        <person name="Khoo S.K."/>
        <person name="Teh B.T."/>
        <person name="Yuen S.T."/>
        <person name="Leung S.Y."/>
        <person name="Wooster R."/>
        <person name="Futreal P.A."/>
        <person name="Stratton M.R."/>
      </authorList>
      <dbReference type="PubMed" id="17344846"/>
      <dbReference type="DOI" id="10.1038/nature05610"/>
    </citation>
    <scope>VARIANT [LARGE SCALE ANALYSIS] LEU-59</scope>
  </reference>
  <reference key="76">
    <citation type="journal article" date="2019" name="Genet. Med." volume="21" first="736" last="742">
      <title>Autozygome and high throughput confirmation of disease genes candidacy.</title>
      <authorList>
        <person name="Maddirevula S."/>
        <person name="Alzahrani F."/>
        <person name="Al-Owain M."/>
        <person name="Al Muhaizea M.A."/>
        <person name="Kayyali H.R."/>
        <person name="AlHashem A."/>
        <person name="Rahbeeni Z."/>
        <person name="Al-Otaibi M."/>
        <person name="Alzaidan H.I."/>
        <person name="Balobaid A."/>
        <person name="El Khashab H.Y."/>
        <person name="Bubshait D.K."/>
        <person name="Faden M."/>
        <person name="Yamani S.A."/>
        <person name="Dabbagh O."/>
        <person name="Al-Mureikhi M."/>
        <person name="Jasser A.A."/>
        <person name="Alsaif H.S."/>
        <person name="Alluhaydan I."/>
        <person name="Seidahmed M.Z."/>
        <person name="Alabbasi B.H."/>
        <person name="Almogarri I."/>
        <person name="Kurdi W."/>
        <person name="Akleh H."/>
        <person name="Qari A."/>
        <person name="Al Tala S.M."/>
        <person name="Alhomaidi S."/>
        <person name="Kentab A.Y."/>
        <person name="Salih M.A."/>
        <person name="Chedrawi A."/>
        <person name="Alameer S."/>
        <person name="Tabarki B."/>
        <person name="Shamseldin H.E."/>
        <person name="Patel N."/>
        <person name="Ibrahim N."/>
        <person name="Abdulwahab F."/>
        <person name="Samira M."/>
        <person name="Goljan E."/>
        <person name="Abouelhoda M."/>
        <person name="Meyer B.F."/>
        <person name="Hashem M."/>
        <person name="Shaheen R."/>
        <person name="AlShahwan S."/>
        <person name="Alfadhel M."/>
        <person name="Ben-Omran T."/>
        <person name="Al-Qattan M.M."/>
        <person name="Monies D."/>
        <person name="Alkuraya F.S."/>
      </authorList>
      <dbReference type="PubMed" id="30237576"/>
      <dbReference type="DOI" id="10.1038/s41436-018-0138-x"/>
    </citation>
    <scope>VARIANT CYS-225</scope>
  </reference>
  <comment type="function">
    <text evidence="5 6 7 9 11 12 13 14 15 16 19 20 22 23 27 30 35 36 37 40 43 44 45 54 55 56 61">Protein kinase involved in the regulation of transcription (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094, PubMed:29335245). Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094, PubMed:30134174). This complex is inactive when in the 7SK snRNP complex form (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR and the negative elongation factors DSIF and NELFE (PubMed:10912001, PubMed:11112772, PubMed:12037670, PubMed:20081228, PubMed:20980437, PubMed:21127351, PubMed:9857195). Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling) (PubMed:17956865, PubMed:18362169). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis (PubMed:10393184, PubMed:11112772). P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export (PubMed:15564463, PubMed:19575011, PubMed:19844166). Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing (PubMed:15564463, PubMed:19575011, PubMed:19844166). The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro (PubMed:21127351). Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage (PubMed:20493174). In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6 (PubMed:20493174). Promotes cardiac myocyte enlargement (PubMed:20081228). RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription (PubMed:21127351). AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect (PubMed:10912001, PubMed:11112772, PubMed:9857195). The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation (PubMed:12037670). Catalyzes phosphorylation of KAT5, promoting KAT5 recruitment to chromatin and histone acetyltransferase activity (PubMed:29335245).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="16 44 55">
      <text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
      <dbReference type="Rhea" id="RHEA:17989"/>
      <dbReference type="Rhea" id="RHEA-COMP:9863"/>
      <dbReference type="Rhea" id="RHEA-COMP:11604"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:29999"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:83421"/>
      <dbReference type="ChEBI" id="CHEBI:456216"/>
      <dbReference type="EC" id="2.7.11.22"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="16 44 55">
      <dbReference type="Rhea" id="RHEA:17990"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="16 44">
      <text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
      <dbReference type="Rhea" id="RHEA:46608"/>
      <dbReference type="Rhea" id="RHEA-COMP:11060"/>
      <dbReference type="Rhea" id="RHEA-COMP:11605"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:30013"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:61977"/>
      <dbReference type="ChEBI" id="CHEBI:456216"/>
      <dbReference type="EC" id="2.7.11.22"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="16 44">
      <dbReference type="Rhea" id="RHEA:46609"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="45 54">
      <text>[DNA-directed RNA polymerase] + ATP = ADP + H(+) + phospho-[DNA-directed RNA polymerase]</text>
      <dbReference type="Rhea" id="RHEA:10216"/>
      <dbReference type="Rhea" id="RHEA-COMP:11321"/>
      <dbReference type="Rhea" id="RHEA-COMP:11322"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:43176"/>
      <dbReference type="ChEBI" id="CHEBI:68546"/>
      <dbReference type="ChEBI" id="CHEBI:456216"/>
      <dbReference type="EC" id="2.7.11.23"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="45 54">
      <dbReference type="Rhea" id="RHEA:10217"/>
    </physiologicalReaction>
  </comment>
  <comment type="activity regulation">
    <text evidence="29 31 34 46 47 49">Inhibited by CDKI-71, CR8, GPC-286199, AG-024322, flavopiridol (alvocidib), RBG-286147, anilinopyrimidine 32, arylazopyrazole 31b, indirubin 3'-monoxime, meriolin 3,P276-00, olomoucine II, pyrazolotriazine, meriolin, variolin, thiazolyl-pyrimidine, thiazolyl-pyrimidine, indirubin-30-monoxime, ZK 304709, AG-012986, AT7519, R547, RGB-286638, imidazole pyrimidine, EXEL-3700, EXEL-8647, 5,6-dichloro-1-b-ribofur-anosyl-benzimidazole (DRB), P276-00, roscovitine (seliciclib, CYC202) and SNS-032 (BMS-387032). Activation by Thr-186 phosphorylation is calcium Ca(2+) signaling pathway-dependent; actively inactivated by dephosphorylation mediated by PPP1CA, PPM1A and PPM1B. Reversibly repressed by acetylation at Lys-44 and Lys-48.</text>
  </comment>
  <comment type="subunit">
    <text evidence="1 5 6 15 16 17 18 21 22 23 25 26 27 28 30 31 32 37 38 39 41 44 45 49 50 52 53 56 60">Component of the super elongation complex (SEC), at least composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb complex and ELL (ELL, ELL2 or ELL3). Associates with CCNT1/cyclin-T1, CCNT2/cyclin-T2 (isoform A and isoform B) or CCNK/cyclin-K to form active P-TEFb. P-TEFb forms a complex with AFF4/AF5Q31 and is part of the super elongation complex (SEC). Component of a complex which is composed of at least 5 members: HTATSF1/Tat-SF1, P-TEFb complex, RNA pol II, SUPT5H and NCL/nucleolin. Associates with UBR5 and forms a transcription regulatory complex composed of CDK9, RNAP II, UBR5 and TFIIS/TCEA1 that can stimulate target gene transcription (e.g. gamma fibrinogen/FGG) by recruiting their promoters. Component of the 7SK snRNP inactive complex which is composed of at least 8 members: P-TEFb (composed of CDK9 and CCNT1/cyclin-T1), HEXIM1, HEXIM2, LARP7, BCDIN3, SART3 proteins and 7SK and U6 snRNAs. This inactive 7SK snRNP complex can also interact with NCOR1 and HDAC3, probably to regulate CDK9 acetylation. Release of P-TEFb from P-TEFb/7SK snRNP complex requires both PP2B to transduce calcium Ca(2+) signaling in response to stimuli (e.g. UV or hexamethylene bisacetamide (HMBA)) and PPP1CA to dephosphorylate Thr-186. This released P-TEFb remains inactive in the pre-initiation complex with BRD4 until new Thr-186 phosphorylation occurs after the synthesis of a short RNA (PubMed:10393184, PubMed:10574912, PubMed:11884399, PubMed:12037670, PubMed:12065898, PubMed:12718890, PubMed:15965233, PubMed:16109376, PubMed:17452463, PubMed:17643375, PubMed:18249148, PubMed:18483222, PubMed:18566585, PubMed:20159561, PubMed:20471948, PubMed:21127351, PubMed:21779453, PubMed:22195968, PubMed:30134174, PubMed:9491887). Interacts with BRD4; to target chromatin binding (PubMed:16109376, PubMed:16109377, PubMed:18483222). Interacts with JMJD6 (PubMed:24360279). Interacts with activated nuclear STAT3 and RELA/p65 (PubMed:17956865, PubMed:18362169). Binds to AR and MYOD1 (PubMed:12037670, PubMed:20980437). Forms a complex composed of CDK9, CCNT1/cyclin-T1, EP300 and GATA4 that stimulates hypertrophy in cardiomyocytes (PubMed:20081228). The large PER complex involved in the repression of transcriptional termination is composed of at least PER2, CDK9, DDX5, DHX9, NCBP1 and POLR2A (By similarity). Interacts with HSF1 (PubMed:27189267). Interacts with TBX21 (By similarity). Isoform 3: binds to KU70/XRCC6 (PubMed:20535204). Interacts with WDR43 (By similarity). Interacts with ZMYND8; the association appears to occur between homodimeric ZMYND8 and the activated form of the P-TEFb complex (PubMed:30134174).</text>
  </comment>
  <comment type="subunit">
    <text evidence="10 60">(Microbial infection) Interacts with the acidic/proline-rich region of HIV-1 and HIV-2 Tat via T-loop region and is thus required for HIV to hijack host transcription machinery during its replication through cooperative binding to viral TAR RNA.</text>
  </comment>
  <comment type="subunit">
    <text evidence="51 58">(Microbial infection) Interacts with human herpes virus 1 (HHV-1) protein ICP22; this interaction blocks the recruitment of positive transcription elongation factor b (P-TEFb) to the viral promoter.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-968983">
      <id>Q13535</id>
      <label>ATR</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-747353">
      <id>Q8WXE1</id>
      <label>ATRIP</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-9345088">
      <id>O60885-1</id>
      <label>BRD4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
      <label>CCNT1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>30</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-2836757">
      <id>O60583</id>
      <label>CCNT2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>10</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-9077118">
      <id>O60583-1</id>
      <label>CCNT2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-9077112">
      <id>O60583-2</id>
      <label>CCNT2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-295634">
      <id>Q16543</id>
      <label>CDC37</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-1369377">
      <id>Q9HAW4</id>
      <label>CLSPN</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-357942">
      <id>Q9NR30</id>
      <label>DDX21</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-306914">
      <id>Q13451</id>
      <label>FKBP5</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>10</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-2832510">
      <id>O94992</id>
      <label>HEXIM1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>17</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-296047">
      <id>P07900</id>
      <label>HSP90AA1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-352572">
      <id>P08238</id>
      <label>HSP90AB1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-8464037">
      <id>Q6NYC1</id>
      <label>JMJD6</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-2371923">
      <id>Q4G0J3</id>
      <label>LARP7</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>18</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-716663">
      <id>P53041</id>
      <label>PPP5C</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-518675">
      <id>P40763</id>
      <label>STAT3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
    </interactant>
    <interactant intactId="EBI-6164389">
      <id>P04608</id>
      <label>tat</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-12029902">
      <id>P50750-2</id>
    </interactant>
    <interactant intactId="EBI-747754">
      <id>P28799</id>
      <label>GRN</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-12029902">
      <id>P50750-2</id>
    </interactant>
    <interactant intactId="EBI-25860013">
      <id>P28799-2</id>
      <label>GRN</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-12029902">
      <id>P50750-2</id>
    </interactant>
    <interactant intactId="EBI-12029900">
      <id>Q6XYB7-2</id>
      <label>LBX2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Nucleus</location>
      <location>PML body</location>
    </subcellularLocation>
    <text>Accumulates on chromatin in response to replication stress. Complexed with CCNT1 in nuclear speckles, but uncomplexed form in the cytoplasm. The translocation from nucleus to cytoplasm is XPO1/CRM1-dependent. Associates with PML body when acetylated.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>P50750-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>P50750-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_016288"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text>Ubiquitous.</text>
  </comment>
  <comment type="induction">
    <text>By replication stress, in chromatin. Probably degraded by the proteasome upon Thr-186 dephosphorylation.</text>
  </comment>
  <comment type="PTM">
    <text evidence="10 21 31 32 33 41 42 46 48 49">Autophosphorylation at Thr-186, Ser-347, Thr-350, Ser-353, Thr-354 and Ser-357 triggers kinase activity by promoting cyclin and substrate binding (e.g. HIV TAT) upon conformational changes. Thr-186 phosphorylation requires the calcium Ca(2+) signaling pathway, including CaMK1D and calmodulin. This inhibition is relieved by Thr-29 dephosphorylation. However, phosphorylation at Thr-29 is inhibitory within the HIV transcription initiation complex. Phosphorylation at Ser-175 inhibits kinase activity. Can be phosphorylated on either Thr-362 or Thr-363 but not on both simultaneously (PubMed:18566585).</text>
  </comment>
  <comment type="PTM">
    <text>Dephosphorylation of Thr-186 by PPM1A and PPM1B blocks CDK9 activity and may lead to CDK9 proteasomal degradation. However, PPP1CA-mediated Thr-186 dephosphorylation is required to release P-TEFb from its inactive P-TEFb/7SK snRNP complex. Dephosphorylation of C-terminus Thr and Ser residues by protein phosphatase-1 (PP1) triggers CDK9 activity, contributing to the activation of HIV-1 transcription.</text>
  </comment>
  <comment type="PTM">
    <text evidence="25 29 54">N6-acetylation of Lys-44 promotes kinase activity, whereas acetylation of both Lys-44 and Lys-48 mediated by PCAF/KAT2B and GCN5/KAT2A reduces kinase activity (PubMed:17452463, PubMed:18250157). The acetylated form associates with PML bodies in the nuclear matrix and with the transcriptionally silent HIV-1 genome; deacetylated upon transcription stimulation (PubMed:17452463, PubMed:18250157). Deacetylated by SIRT7, promoting the kinase activity and subsequent 'Ser-2' phosphorylation of the C-terminal domain (CTD) of RNA polymerase II (PubMed:28426094).</text>
  </comment>
  <comment type="PTM">
    <text evidence="45">Polyubiquitinated and thus activated by UBR5. This ubiquitination is promoted by TFIIS/TCEA1 and favors 'Ser-2' phosphorylation of RPB1/POLR2A CTD.</text>
  </comment>
  <comment type="disease">
    <text>Chronic activation of CDK9 causes cardiac myocyte enlargement leading to cardiac hypertrophy and confers predisposition to heart failure.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="65 66">CDK9 inhibition contributes to the anticancer activity of most CDK inhibitors under clinical investigation (PubMed:18423896, PubMed:21779453). As a retroviruses target during the hijack of host transcription (e.g. HIV), CDK9 inhibitors might become specific antiretroviral agents (PubMed:18423896). May be a target for cardiac hypertrophy future treatments (PubMed:18423896, PubMed:19757441). May also be a target in anti-inflammatory therapy in innate immunity and systemic inflammation (PubMed:18728388).</text>
  </comment>
  <comment type="similarity">
    <text evidence="64">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.</text>
  </comment>
  <dbReference type="EC" id="2.7.11.22" evidence="16 44"/>
  <dbReference type="EC" id="2.7.11.23" evidence="45 54"/>
  <dbReference type="EMBL" id="L25676">
    <property type="protein sequence ID" value="AAA35668.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X80230">
    <property type="protein sequence ID" value="CAA56516.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF255306">
    <property type="protein sequence ID" value="AAF72183.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BT019903">
    <property type="protein sequence ID" value="AAV38706.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF517840">
    <property type="protein sequence ID" value="AAM54039.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL162586">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC001968">
    <property type="protein sequence ID" value="AAH01968.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS6879.1">
    <molecule id="P50750-1"/>
  </dbReference>
  <dbReference type="PIR" id="A55262">
    <property type="entry name" value="A55262"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001252.1">
    <molecule id="P50750-1"/>
    <property type="nucleotide sequence ID" value="NM_001261.3"/>
  </dbReference>
  <dbReference type="PDB" id="3BLH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.48 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3BLQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3BLR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3LQ5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3MI9">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A=1-345"/>
  </dbReference>
  <dbReference type="PDB" id="3MIA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A=1-345"/>
  </dbReference>
  <dbReference type="PDB" id="3MY1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3TN8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.95 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3TNH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="3TNI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.23 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4BCF">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.01 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4BCG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.08 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4BCH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.96 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4BCI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4BCJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.16 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="4EC8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="A=2-372"/>
  </dbReference>
  <dbReference type="PDB" id="4EC9">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.21 A"/>
    <property type="chains" value="A=2-372"/>
  </dbReference>
  <dbReference type="PDB" id="4IMY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.94 A"/>
    <property type="chains" value="A/C/E=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="4OGR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A/E/I=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="4OR5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A/F=7-332"/>
  </dbReference>
  <dbReference type="PDB" id="5L1Z">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="5.90 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="6CYT">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.50 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="6GZH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.17 A"/>
    <property type="chains" value="A=1-326"/>
  </dbReference>
  <dbReference type="PDB" id="6W9E">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="6Z45">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.37 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="7NWK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.81 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDB" id="8I0L">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="A=2-330"/>
  </dbReference>
  <dbReference type="PDB" id="8K5R">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.75 A"/>
    <property type="chains" value="A=1-330"/>
  </dbReference>
  <dbReference type="PDBsum" id="3BLH"/>
  <dbReference type="PDBsum" id="3BLQ"/>
  <dbReference type="PDBsum" id="3BLR"/>
  <dbReference type="PDBsum" id="3LQ5"/>
  <dbReference type="PDBsum" id="3MI9"/>
  <dbReference type="PDBsum" id="3MIA"/>
  <dbReference type="PDBsum" id="3MY1"/>
  <dbReference type="PDBsum" id="3TN8"/>
  <dbReference type="PDBsum" id="3TNH"/>
  <dbReference type="PDBsum" id="3TNI"/>
  <dbReference type="PDBsum" id="4BCF"/>
  <dbReference type="PDBsum" id="4BCG"/>
  <dbReference type="PDBsum" id="4BCH"/>
  <dbReference type="PDBsum" id="4BCI"/>
  <dbReference type="PDBsum" id="4BCJ"/>
  <dbReference type="PDBsum" id="4EC8"/>
  <dbReference type="PDBsum" id="4EC9"/>
  <dbReference type="PDBsum" id="4IMY"/>
  <dbReference type="PDBsum" id="4OGR"/>
  <dbReference type="PDBsum" id="4OR5"/>
  <dbReference type="PDBsum" id="5L1Z"/>
  <dbReference type="PDBsum" id="6CYT"/>
  <dbReference type="PDBsum" id="6GZH"/>
  <dbReference type="PDBsum" id="6W9E"/>
  <dbReference type="PDBsum" id="6Z45"/>
  <dbReference type="PDBsum" id="7NWK"/>
  <dbReference type="PDBsum" id="8I0L"/>
  <dbReference type="PDBsum" id="8K5R"/>
  <dbReference type="AlphaFoldDB" id="P50750"/>
  <dbReference type="SMR" id="P50750"/>
  <dbReference type="BioGRID" id="107459">
    <property type="interactions" value="693"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-222">
    <property type="entry name" value="Positive transcription elongation factor B, CDK9-cyclinT1 complex"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-321">
    <property type="entry name" value="Positive transcription elongation factor B, CDK9-cyclinT2a complex"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-322">
    <property type="entry name" value="Positive transcription elongation factor B, CDK9-cyclinT2b complex"/>
  </dbReference>
  <dbReference type="CORUM" id="P50750"/>
  <dbReference type="DIP" id="DIP-29016N"/>
  <dbReference type="ELM" id="P50750"/>
  <dbReference type="IntAct" id="P50750">
    <property type="interactions" value="110"/>
  </dbReference>
  <dbReference type="MINT" id="P50750"/>
  <dbReference type="STRING" id="9606.ENSP00000362361"/>
  <dbReference type="BindingDB" id="P50750"/>
  <dbReference type="ChEMBL" id="CHEMBL3116"/>
  <dbReference type="DrugBank" id="DB03496">
    <property type="generic name" value="Alvocidib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB06195">
    <property type="generic name" value="Seliciclib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB15442">
    <property type="generic name" value="Trilaciclib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB16656">
    <property type="generic name" value="Zotiraciclib"/>
  </dbReference>
  <dbReference type="DrugCentral" id="P50750"/>
  <dbReference type="GuidetoPHARMACOLOGY" id="1981"/>
  <dbReference type="GlyGen" id="P50750">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P50750"/>
  <dbReference type="PhosphoSitePlus" id="P50750"/>
  <dbReference type="SwissPalm" id="P50750"/>
  <dbReference type="BioMuta" id="CDK9"/>
  <dbReference type="DMDM" id="68067660"/>
  <dbReference type="CPTAC" id="CPTAC-1602"/>
  <dbReference type="CPTAC" id="CPTAC-2941"/>
  <dbReference type="CPTAC" id="CPTAC-2942"/>
  <dbReference type="jPOST" id="P50750"/>
  <dbReference type="MassIVE" id="P50750"/>
  <dbReference type="PaxDb" id="9606-ENSP00000362361"/>
  <dbReference type="PeptideAtlas" id="P50750"/>
  <dbReference type="ProteomicsDB" id="56263">
    <molecule id="P50750-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="56264">
    <molecule id="P50750-2"/>
  </dbReference>
  <dbReference type="Pumba" id="P50750"/>
  <dbReference type="Antibodypedia" id="1447">
    <property type="antibodies" value="635 antibodies from 42 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="1025"/>
  <dbReference type="Ensembl" id="ENST00000373264.5">
    <molecule id="P50750-1"/>
    <property type="protein sequence ID" value="ENSP00000362361.4"/>
    <property type="gene ID" value="ENSG00000136807.14"/>
  </dbReference>
  <dbReference type="GeneID" id="1025"/>
  <dbReference type="KEGG" id="hsa:1025"/>
  <dbReference type="MANE-Select" id="ENST00000373264.5">
    <property type="protein sequence ID" value="ENSP00000362361.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_001261.4"/>
    <property type="RefSeq protein sequence ID" value="NP_001252.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc004bse.3">
    <molecule id="P50750-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:1780"/>
  <dbReference type="CTD" id="1025"/>
  <dbReference type="DisGeNET" id="1025"/>
  <dbReference type="GeneCards" id="CDK9"/>
  <dbReference type="HGNC" id="HGNC:1780">
    <property type="gene designation" value="CDK9"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000136807">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="603251">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P50750"/>
  <dbReference type="OpenTargets" id="ENSG00000136807"/>
  <dbReference type="PharmGKB" id="PA26316"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000136807"/>
  <dbReference type="eggNOG" id="KOG0669">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000155373"/>
  <dbReference type="HOGENOM" id="CLU_000288_181_1_1"/>
  <dbReference type="InParanoid" id="P50750"/>
  <dbReference type="OMA" id="MQGPTEQ"/>
  <dbReference type="OrthoDB" id="244018at2759"/>
  <dbReference type="PhylomeDB" id="P50750"/>
  <dbReference type="TreeFam" id="TF101039"/>
  <dbReference type="BRENDA" id="2.7.11.22">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="BRENDA" id="2.7.11.23">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="P50750"/>
  <dbReference type="Reactome" id="R-HSA-112382">
    <property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167152">
    <property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167200">
    <property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167238">
    <property type="pathway name" value="Pausing and recovery of Tat-mediated HIV elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167243">
    <property type="pathway name" value="Tat-mediated HIV elongation arrest and recovery"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167246">
    <property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167287">
    <property type="pathway name" value="HIV elongation arrest and recovery"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167290">
    <property type="pathway name" value="Pausing and recovery of HIV elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-176034">
    <property type="pathway name" value="Interactions of Tat with host cellular proteins"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-2173796">
    <property type="pathway name" value="SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-674695">
    <property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6796648">
    <property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6807505">
    <property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-75955">
    <property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9018519">
    <property type="pathway name" value="Estrogen-dependent gene expression"/>
  </dbReference>
  <dbReference type="SignaLink" id="P50750"/>
  <dbReference type="SIGNOR" id="P50750"/>
  <dbReference type="BioGRID-ORCS" id="1025">
    <property type="hits" value="874 hits in 1185 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="CDK9">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P50750"/>
  <dbReference type="GeneWiki" id="CDK9"/>
  <dbReference type="GeneWiki" id="Cyclin-dependent_kinase_9"/>
  <dbReference type="GenomeRNAi" id="1025"/>
  <dbReference type="Pharos" id="P50750">
    <property type="development level" value="Tchem"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P50750"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 9"/>
  </dbReference>
  <dbReference type="RNAct" id="P50750">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000136807">
    <property type="expression patterns" value="Expressed in right uterine tube and 137 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P50750">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008024">
    <property type="term" value="C:cyclin/CDK positive transcription elongation factor complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0036464">
    <property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070691">
    <property type="term" value="C:P-TEFb complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016605">
    <property type="term" value="C:PML body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008023">
    <property type="term" value="C:transcription elongation factor complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097322">
    <property type="term" value="F:7SK snRNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003682">
    <property type="term" value="F:chromatin binding"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004693">
    <property type="term" value="F:cyclin-dependent protein serine/threonine kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016301">
    <property type="term" value="F:kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="DisProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004672">
    <property type="term" value="F:protein kinase activity"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019901">
    <property type="term" value="F:protein kinase binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0106310">
    <property type="term" value="F:protein serine kinase activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="RHEA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004674">
    <property type="term" value="F:protein serine/threonine kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000978">
    <property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008353">
    <property type="term" value="F:RNA polymerase II CTD heptapeptide repeat kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001223">
    <property type="term" value="F:transcription coactivator binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003711">
    <property type="term" value="F:transcription elongation factor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008283">
    <property type="term" value="P:cell population proliferation"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071345">
    <property type="term" value="P:cellular response to cytokine stimulus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006281">
    <property type="term" value="P:DNA repair"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0120186">
    <property type="term" value="P:negative regulation of protein localization to chromatin"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051647">
    <property type="term" value="P:nucleus localization"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="DisProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043923">
    <property type="term" value="P:positive regulation by host of viral transcription"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="GO" id="GO:0120187">
    <property type="term" value="P:positive regulation of protein localization to chromatin"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045944">
    <property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032968">
    <property type="term" value="P:positive regulation of transcription elongation by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006468">
    <property type="term" value="P:protein phosphorylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051726">
    <property type="term" value="P:regulation of cell cycle"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006282">
    <property type="term" value="P:regulation of DNA repair"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031440">
    <property type="term" value="P:regulation of mRNA 3'-end processing"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051147">
    <property type="term" value="P:regulation of muscle cell differentiation"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031297">
    <property type="term" value="P:replication fork processing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006366">
    <property type="term" value="P:transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006368">
    <property type="term" value="P:transcription elongation by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140673">
    <property type="term" value="P:transcription elongation-coupled chromatin remodeling"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006367">
    <property type="term" value="P:transcription initiation at RNA polymerase II promoter"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="CDD" id="cd07865">
    <property type="entry name" value="STKc_CDK9"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="DisProt" id="DP01309"/>
  <dbReference type="Gene3D" id="1.10.510.10">
    <property type="entry name" value="Transferase(Phosphotransferase) domain 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR050108">
    <property type="entry name" value="CDK"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR011009">
    <property type="entry name" value="Kinase-like_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000719">
    <property type="entry name" value="Prot_kinase_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR017441">
    <property type="entry name" value="Protein_kinase_ATP_BS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR008271">
    <property type="entry name" value="Ser/Thr_kinase_AS"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR24056">
    <property type="entry name" value="CELL DIVISION PROTEIN KINASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR24056:SF546">
    <property type="entry name" value="CYCLIN-DEPENDENT KINASE 9"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00069">
    <property type="entry name" value="Pkinase"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00220">
    <property type="entry name" value="S_TKc"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF56112">
    <property type="entry name" value="Protein kinase-like (PK-like)"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00107">
    <property type="entry name" value="PROTEIN_KINASE_ATP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50011">
    <property type="entry name" value="PROTEIN_KINASE_DOM"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00108">
    <property type="entry name" value="PROTEIN_KINASE_ST"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0227">DNA damage</keyword>
  <keyword id="KW-0234">DNA repair</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-0418">Kinase</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0808">Transferase</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="chain" id="PRO_0000085800" description="Cyclin-dependent kinase 9">
    <location>
      <begin position="1"/>
      <end position="372"/>
    </location>
  </feature>
  <feature type="domain" description="Protein kinase" evidence="2">
    <location>
      <begin position="19"/>
      <end position="315"/>
    </location>
  </feature>
  <feature type="region of interest" description="T-loop">
    <location>
      <begin position="166"/>
      <end position="191"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="4">
    <location>
      <begin position="343"/>
      <end position="372"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="4">
    <location>
      <begin position="345"/>
      <end position="372"/>
    </location>
  </feature>
  <feature type="active site" description="Proton acceptor" evidence="2 3">
    <location>
      <position position="149"/>
    </location>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <begin position="25"/>
      <end position="33"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2 32">
    <location>
      <position position="48"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2 32">
    <location>
      <begin position="104"/>
      <end position="106"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2 32">
    <location>
      <position position="167"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine; by EP300/CBP, PCAF/KAT2B and GCN5/KAT2A" evidence="25 29">
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine; by PCAF/KAT2B and GCN5/KAT2A" evidence="29 54">
    <location>
      <position position="48"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="48">
    <location>
      <position position="175"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by CaMK1D" evidence="21 31 32 33 41 42 46 49 70">
    <location>
      <position position="186"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by CDK9 and PKA" evidence="10 32 68 69 71">
    <location>
      <position position="347"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="10 69">
    <location>
      <position position="350"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by CDK9" evidence="10">
    <location>
      <position position="353"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="10">
    <location>
      <position position="354"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by CDK9" evidence="10">
    <location>
      <position position="357"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="32">
    <location>
      <position position="362"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="32">
    <location>
      <position position="363"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_016288" description="In isoform 2." evidence="64">
    <original>M</original>
    <variation>MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGPGGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAAM</variation>
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_041982" description="In dbSNP:rs55640715." evidence="24">
    <original>F</original>
    <variation>L</variation>
    <location>
      <position position="59"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_082140" description="Found in patients with global developmental delay and epilepsy with history of choanal atresia; uncertain significance; dbSNP:rs767418586." evidence="57">
    <original>R</original>
    <variation>C</variation>
    <location>
      <position position="225"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013456" evidence="8 59">
    <original>G</original>
    <variation>A</variation>
    <location>
      <position position="231"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impaired kinase and transcriptional elongation activities, but normal cyclin T1 and HEXIM1 binding." evidence="25">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Mimics acetylation; leading to impaired protein kinase activity." evidence="54">
    <original>K</original>
    <variation>Q</variation>
    <location>
      <position position="48"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased acetylation; leading to enhanced protein kinase activity." evidence="54">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="48"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abrogates kinase activity." evidence="10 12">
    <original>D</original>
    <variation>N</variation>
    <location>
      <position position="167"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Constitutive kinase activity." evidence="48">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="175"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Mimics phosphorylation, constitutive loss of kinase activity." evidence="48">
    <original>S</original>
    <variation>D</variation>
    <location>
      <position position="175"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation." evidence="12 32 46">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="186"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Mimics autophosphorylation; constitutive kinase activity, independently of calcium signaling." evidence="12 32 46">
    <original>T</original>
    <variation>D</variation>
    <location>
      <position position="186"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of autophosphorylation and impaired interaction with HIVTAT." evidence="10">
    <original>SQITQQSTNQS</original>
    <variation>AQIAQQAANQA</variation>
    <location>
      <begin position="347"/>
      <end position="357"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Mimics autophosphorylation and promotes interaction with HIVTAT." evidence="10">
    <original>SQITQQSTNQS</original>
    <variation>EQIEQQEENQE</variation>
    <location>
      <begin position="347"/>
      <end position="357"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 4; AAV38706." evidence="64" ref="4">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="163"/>
    </location>
  </feature>
  <feature type="strand" evidence="77">
    <location>
      <begin position="11"/>
      <end position="13"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="16"/>
      <end position="18"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="19"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="28"/>
      <end position="30"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="32"/>
      <end position="38"/>
    </location>
  </feature>
  <feature type="turn" evidence="74">
    <location>
      <begin position="39"/>
      <end position="41"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="44"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="56"/>
      <end position="59"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="61"/>
      <end position="72"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="81"/>
      <end position="87"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="98"/>
      <end position="104"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="107"/>
      <end position="109"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="110"/>
      <end position="115"/>
    </location>
  </feature>
  <feature type="strand" evidence="73">
    <location>
      <begin position="116"/>
      <end position="118"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="123"/>
      <end position="142"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="152"/>
      <end position="154"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="155"/>
      <end position="157"/>
    </location>
  </feature>
  <feature type="strand" evidence="77">
    <location>
      <begin position="159"/>
      <end position="161"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="163"/>
      <end position="165"/>
    </location>
  </feature>
  <feature type="helix" evidence="76">
    <location>
      <begin position="168"/>
      <end position="170"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="178"/>
      <end position="181"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="192"/>
      <end position="194"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="197"/>
      <end position="200"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="209"/>
      <end position="224"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="234"/>
      <end position="245"/>
    </location>
  </feature>
  <feature type="turn" evidence="74">
    <location>
      <begin position="250"/>
      <end position="252"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="256"/>
      <end position="258"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="260"/>
      <end position="262"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="263"/>
      <end position="265"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="275"/>
      <end position="283"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="286"/>
      <end position="295"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="300"/>
      <end position="302"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="306"/>
      <end position="310"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="313"/>
      <end position="316"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="317"/>
      <end position="319"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="325"/>
      <end position="329"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="335"/>
      <end position="339"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="68 69">
    <location sequence="P50750-2">
      <position position="35"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="71">
    <location sequence="P50750-2">
      <position position="54"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="Q99J95"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00159"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="3">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU10027"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="4">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="10393184"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="10574912"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="10757782"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="10903437"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="10912001"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="10958691"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="11112772"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="11145967"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="11575923"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="11809800"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="11884399"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="12037670"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="12065898"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="12718890"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="14701750"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="15564463"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="15965233"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="16109376"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="16109377"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="17344846"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="17452463"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="17643375"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="17956865"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="18249148"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="18250157"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="18362169"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="18483222"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="18566585"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="18829461"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="19238148"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="19575011"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="19844166"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="20081228"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="20159561"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="20471948"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source>
      <dbReference type="PubMed" id="20493174"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="41">
    <source>
      <dbReference type="PubMed" id="20535204"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="42">
    <source>
      <dbReference type="PubMed" id="20851342"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="43">
    <source>
      <dbReference type="PubMed" id="20930849"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="44">
    <source>
      <dbReference type="PubMed" id="20980437"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="45">
    <source>
      <dbReference type="PubMed" id="21127351"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="46">
    <source>
      <dbReference type="PubMed" id="21448926"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="47">
    <source>
      <dbReference type="PubMed" id="21484792"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="48">
    <source>
      <dbReference type="PubMed" id="21533037"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="49">
    <source>
      <dbReference type="PubMed" id="21779453"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="50">
    <source>
      <dbReference type="PubMed" id="22195968"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="51">
    <source>
      <dbReference type="PubMed" id="23029222"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="52">
    <source>
      <dbReference type="PubMed" id="24360279"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="53">
    <source>
      <dbReference type="PubMed" id="27189267"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="54">
    <source>
      <dbReference type="PubMed" id="28426094"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="55">
    <source>
      <dbReference type="PubMed" id="29335245"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="56">
    <source>
      <dbReference type="PubMed" id="30134174"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="57">
    <source>
      <dbReference type="PubMed" id="30237576"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="58">
    <source>
      <dbReference type="PubMed" id="34696162"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="59">
    <source>
      <dbReference type="PubMed" id="7695608"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="60">
    <source>
      <dbReference type="PubMed" id="9491887"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="61">
    <source>
      <dbReference type="PubMed" id="9857195"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="62">
    <source>
      <dbReference type="PubMed" id="10903437"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="63">
    <source>
      <dbReference type="PubMed" id="8170997"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="64"/>
  <evidence type="ECO:0000305" key="65">
    <source>
      <dbReference type="PubMed" id="18423896"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="66">
    <source>
      <dbReference type="PubMed" id="18728388"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="67">
    <source>
      <dbReference type="HGNC" id="HGNC:1780"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="68">
    <source>
      <dbReference type="PubMed" id="18691976"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="69">
    <source>
      <dbReference type="PubMed" id="19369195"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="70">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="71">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="72">
    <source>
      <dbReference type="PDB" id="3BLR"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="73">
    <source>
      <dbReference type="PDB" id="3LQ5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="74">
    <source>
      <dbReference type="PDB" id="3MI9"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="75">
    <source>
      <dbReference type="PDB" id="3MY1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="76">
    <source>
      <dbReference type="PDB" id="4OGR"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="77">
    <source>
      <dbReference type="PDB" id="6GZH"/>
    </source>
  </evidence>
  <sequence length="372" mass="42778" checksum="69E851CC6F7A0388" modified="2005-06-21" version="3">MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>